Home   >  
Microbiology/Virology
  >  
Antibiotic
  >   Sitafloxacin
Sitafloxacin Chemical Structure

Sitafloxacin

Data Sheet For research use only. Not for human use.
Cat. No. :BCP06084CAS No. :127254-12-0Purity:99%
 Tel: 0086-13026320035   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Chemical Properties&Biological Activity
CAS No. 127254-12-0 Cat. No. BCP06084
Related Products 163253-35-8(Sitafloxacin hydrate (2:3)) 346607-37-2(Sitafloxacin hydrochloride)
Name Sitafloxacin
Synonyms DU-6859a;DU6859a;DU 6859a;Gracevit;
SMILES
Chemical Name
Formula C19H18ClF2N3O3 M. Wt 409.81
Purity 99% Storage Store at 4-8°C
Description Sitafloxacin, a new-generation, broad-spectrum oral fluoroquinolone that is very active against many Gram-positive, Gram-negative and anaerobic clinical isolates, including strains resistant to other fluoroquinolones, was recently approved in Japan for the treatment of respiratory and urinary tract infections. In terms of clinical efficacy, oral sitafloxacin was noninferior to oral levofloxacin in the treatment of community-acquired pneumonia or an infectious exacerbation of chronic respiratory tract disease, noninferior to oral tosufloxacin in the treatment of community-acquired pneumonia, and noninferior to oral levofloxacin in the treatment of complicated urinary tract infections, according to the results of randomized, double-blind, multicentre, noninferiority trials. Noncomparative studies demonstrated the efficacy of oral sitafloxacin in otorhinolaryngological infections, urethritis in men, C. trachomatis-associated cervicitis in women and odontogenic infections .
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:Sitafloxacin supplier,Sitafloxacin purchase,Sitafloxacin manufacturer,Sitafloxacin distributor,Sitafloxacin cost,Sitafloxacin buy,Sitafloxacin for sale

0086-13720134139